SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-22-008438
Filing Date
2022-05-12
Accepted
2022-05-12 07:36:52
Documents
82
Period of Report
2022-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q aplt-20220331x10q.htm   iXBRL 10-Q 1740251
2 EX-31.1 aplt-20220331xex31d1.htm EX-31.1 9713
3 EX-31.2 aplt-20220331xex31d2.htm EX-31.2 9711
4 EX-32.1 aplt-20220331xex32d1.htm EX-32.1 6232
5 EX-32.2 aplt-20220331xex32d2.htm EX-32.2 6386
  Complete submission text file 0001558370-22-008438.txt   7389363

Data Files

Seq Description Document Type Size
6 EX-101.SCH aplt-20220331.xsd EX-101.SCH 58291
7 EX-101.CAL aplt-20220331_cal.xml EX-101.CAL 54245
8 EX-101.DEF aplt-20220331_def.xml EX-101.DEF 203158
9 EX-101.LAB aplt-20220331_lab.xml EX-101.LAB 479984
10 EX-101.PRE aplt-20220331_pre.xml EX-101.PRE 387442
76 EXTRACTED XBRL INSTANCE DOCUMENT aplt-20220331x10q_htm.xml XML 1242780
Mailing Address 545 5TH AVENUE, SUITE 1400 NEW YORK NY 10017
Business Address 545 5TH AVENUE, SUITE 1400 NEW YORK NY 10017 212-220-9319
Applied Therapeutics Inc. (Filer) CIK: 0001697532 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38898 | Film No.: 22915739
SIC: 2834 Pharmaceutical Preparations